- Home
- TRN vs APGE Comparison
TRN vs APGE Comparison
Compare TRN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRN
- APGE
- Stock Information
- Founded
- TRN 1933
- APGE 2022
- Country
- TRN United States
- APGE United States
- Employees
- TRN N/A
- APGE N/A
- Industry
- TRN Railroads
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRN Industrials
- APGE Health Care
- Exchange
- TRN Nasdaq
- APGE Nasdaq
- Market Cap
- TRN 2.9B
- APGE 3.0B
- IPO Year
- TRN N/A
- APGE 2023
- Fundamental
- Price
- TRN $35.83
- APGE $47.32
- Analyst Decision
- TRN Buy
- APGE Strong Buy
- Analyst Count
- TRN 2
- APGE 6
- Target Price
- TRN $34.00
- APGE $75.40
- AVG Volume (30 Days)
- TRN 491.3K
- APGE 581.6K
- Earning Date
- TRN 02-20-2025
- APGE 11-12-2024
- Dividend Yield
- TRN 3.14%
- APGE N/A
- EPS Growth
- TRN 128.94
- APGE N/A
- EPS
- TRN 2.05
- APGE N/A
- Revenue
- TRN $3,247,700,000.00
- APGE N/A
- Revenue This Year
- TRN $2.77
- APGE N/A
- Revenue Next Year
- TRN N/A
- APGE N/A
- P/E Ratio
- TRN $15.93
- APGE N/A
- Revenue Growth
- TRN 16.97
- APGE N/A
- 52 Week Low
- TRN $23.40
- APGE $27.05
- 52 Week High
- TRN $39.00
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- TRN 44.55
- APGE 48.41
- Support Level
- TRN $34.90
- APGE $43.69
- Resistance Level
- TRN $36.59
- APGE $48.42
- Average True Range (ATR)
- TRN 1.11
- APGE 3.53
- MACD
- TRN -0.31
- APGE 0.31
- Stochastic Oscillator
- TRN 29.56
- APGE 49.41
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in the industries of agriculture, construction, consumer products, energy, and chemicals.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.